Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk
New generics in Canada likely mark the start of a decline in international revenue of semaglutide, the active ingredient in Novo's Ozempic and Wegovy.
ORIGINAL SOURCE →via CNBC Top News
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · CA
- [ENERGY] Canadian Natural Says Pipeline Needed to Unlock Oil Sands Growth
- [ENERGY] Canadian Natural Says Pipeline Needed to Unlock Oil Sands Growth - Crude Oil Prices Today | OilPrice.com
- [CONFLICT] U.S. sanctions new head of Cuban military firm; Canada’s Sherritt suspends Cuba operations - Miami Herald
- [FINANCE] Raymond James upgrades Canadian Natural Resources stock rating on valuation
- [HEALTH] Seasonal COVID-19 vaccination in 2025/26 reduced risk of illness by half in Canada
- [ENERGY] Canadian Oil Producers Push for New Pipelines Amid Rising Output - Crude Oil Prices Today | OilPrice.com